Spotlight Stocks: UBS, IBM, United Health, Acme Packet-Minyanville

Spotlight Stocks: UBS, IBM, United Health, Acme Packet

Minyanville Staff Jul 03, 2008 9:51 am

Spotlight Stocks: UBS, IBM, United Health, Acme Packet


		Thursday's top stories and stocks with potential to move.

Stocks to watch for Thursday, July 3rd:

UBS (UBS) may post an additional $6.9 billion in writedowns. This according to Citigroup, itself no stranger to writedowns. The financial services firm still carries, according to Citi analyst Peter Kurer, $83 billion in risk exposure.
IBM (IBM) has agreed to buy Platform Solutions. According to the Wall Street Journal, the deal eliminates both ongoing litigation and a potential competitor in the lucrative mainframe business.
UnitedHealth Group (UNH) had its ratings outlook lowered to negative from stable by Standard & Poor’s. The downgrade came after the health insurer cut its earnings outlook - again. S&P also affirmed its A- counterparty credit rating on the company.
Acme Packet (APKT) issued downside guidance for the second quarter: Between $0.02 and $0.04 per share versus consensus estimates of $0.09, and revenues between $24.5 and $25.5 million versus consensus estimates of $33.6 million. A company spokesperson said results were hampered by transactions that failed to close in the anticipated timeframe and the shipment of product in the waning days of the second quarter that, as such, couldn’t be factored for the quarter.
NVIDIA Corporation (NVDA) announced Wednesday after the closing bell that it expects second-quarter revenue and gross margins to miss previously announced forecasts. The Santa Clara, California-based chipmaker revised its revenue expectations and now estimates a haul of between $875 and $950 million.

STOCKS
RELATED ARTICLES
ALSO BY...


Rate this article:			(0 Votes)

more BUSINESS & MARKETS articles »

Daily Article Index �

tags:

APKT, UNITEDHEALTH, ACME, PACKET

Comment (0)

See All Comments »


discuss this article and more on the mv exchange

No positions in stocks mentioned.

Get real-time options trading ideas from Steve Smith, veteran options trader and newsletter author, plus let him show you the way to cut risk and boost your returns through the strategic use of options. Click here for a free 14 day trial to OptionSmith by Steve Smith.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2009 Minyanville Media, Inc. All Rights Reserved.